The HAT trial contains a retaining ring that has shown the potential to disengage during use.
Source facts
Action
The firm issued letters dated 5/11/2021 explaining the issue, the clinical impact, and instructing the consignee to immediately cease distribution or use of the product. The information was to be extended to their accounts who may have the product in their possession.
Initiated
2021-05-11
Root cause
Device Design
Distribution
US Nationwide distribution in the states of AZ, CO, FL, NY, SC, and TN. There was no foreign/government/military distribution.
Recall number
Z-1977-2021
Recall status
Completed
CDRH record ID
187594
FDA record created
2021-06-29
Recall event number
87989
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.